Skip to main content

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.